arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

GSK plc

GSK Health Care Biotechnology: Pharmaceutical Preparations
$49.87
▼ -0.1% Today
as of Sep 4, 16:49 ET
Last 30 days -7.11% Jul 28 → Sep 04
$49.18 $50.40 $51.61 $52.83 $54.05 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$49.70
High
$50.06
Low
$49.66
Volume
$2M
Avg Vol
$5M
Mkt Cap
$104.5B
P/E (TTM)
—
Beta
—
52w High
$61.70
52w Low
$39.29
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 3 ● 22 ▼ 0
Sep 5 · 00:50 Insider Monkey neutral
Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
Sep 4 · 10:10 Proactive neutral
GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says
Sep 3 · 09:30 RATING Proactive neutral
Panmure and Cavendish reiterate buy on Hutchmed after GSK deal
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$39
$62
47% of range
Avg surprise (last 2)
+7.2%
Avg reaction (last 1)
+2.3%
100% positive
Latest IV / EM
49%
EM ±2.0% · $51 · Sep 4

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.08$1.12$1.16$1.19$1.23 Actual $1.13Est $1.08Actual $1.23Est $1.12 Mar/2025Jun/2025

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 30, 2025Jun/2025 $1.23 $1.12 +9.8% — — earnings
Wed Apr 30, 2025Mar/2025 $1.13 $1.08 +4.6% — +2.3% earnings

Implied volatility — last 90 days

21%38%55%71%88% Jun 07 — IV 36% · EM ±3.4%Jun 08 — IV 35% · EM ±2.9%Jun 09 — IV 37% · EM ±2.7%Jun 10 — IV 43% · EM ±2.5%Jun 15 — IV 44% · EM ±3.2%Jun 16 — IV 32% · EM ±1.9%Jun 17 — IV 34% · EM ±1.4%Jun 19 — IV 27% · EM ±3.0%Jun 22 — IV 29% · EM ±2.4%Jun 23 — IV 28% · EM ±2.0%Jun 24 — IV 45% · EM ±2.6%Jun 25 — IV 37% · EM ±1.5%Jun 29 — IV 36% · EM ±8.4%Jun 30 — IV 34% · EM ±7.9%Jul 01 — IV 41% · EM ±9.4%Jul 02 — IV 32% · EM ±7.2%Jul 03 — IV 32% · EM ±7.2%Jul 06 — IV 34% · EM ±7.2%Jul 07 — IV 35% · EM ±7.1%Jul 08 — IV 36% · EM ±7.2%Jul 09 — IV 34% · EM ±6.6%Jul 10 — IV 34% · EM ±6.6%Jul 13 — IV 37% · EM ±6.5%Jul 14 — IV 38% · EM ±6.5%Jul 15 — IV 37% · EM ±6.2%Jul 16 — IV 38% · EM ±6.1%Jul 17 — IV 38% · EM ±5.9%Jul 20 — IV 40% · EM ±5.5%Jul 21 — IV 41% · EM ±5.4%Jul 22 — IV 42% · EM ±5.2%Jul 23 — IV 46% · EM ±5.4%Jul 24 — IV 46% · EM ±5.1%Jul 27 — IV 51% · EM ±4.2%Jul 28 — IV 32% · EM ±2.3%Jul 29 — IV 37% · EM ±2.2%Jul 30 — IV 25% · EM ±1.1%Aug 03 — IV 35% · EM ±3.0%Aug 04 — IV 34% · EM ±2.4%Aug 05 — IV 89% · EM ±5.2%Aug 06 — IV 25% · EM ±1.1%Aug 10 — IV 36% · EM ±3.0%Aug 11 — IV 60% · EM ±4.3%Aug 13 — IV 45% · EM ±1.9%Aug 17 — IV 30% · EM ±2.5%Aug 18 — IV 30% · EM ±2.2%Aug 19 — IV 31% · EM ±1.8%Aug 20 — IV 31% · EM ±1.3%Aug 24 — IV 24% · EM ±2.0%Aug 25 — IV 21% · EM ±1.5%Aug 26 — IV 53% · EM ±3.1%Aug 27 — IV 38% · EM ±1.6%Aug 31 — IV 30% · EM ±2.5%Sep 01 — IV 36% · EM ±2.6%Sep 02 — IV 38% · EM ±2.2%Sep 03 — IV 49% · EM ±2.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in